Boston Scientific Launches Precision Spectra™ Spinal Cord Stimulator System In The United States (via PR Newswire)
World’s First and Only System with Illumina 3D™ Software and 32 Contacts is Designed to Provide Pain Relief to a Broad Spectrum of Chronic Pain Patients NATICK, Mass., April 12, 2013 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has received approval by the U.S. Food and Drug Administration…
published: April 15, 2013 in: Approval/Clearance, Boston Scientific, Launches / Withdrawals, Pain management